Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure

Digestive and Liver Disease

Volumn 36, Issue 6, 2004, Pages 419-422

  Kayacetin, E ^a,c   Koklu S ^b   Temucin T ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Autoimmune hepatitis; Fulminant hepatic failure; Primary biliary cirrhosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; MITOCHONDRION ANTIBODY; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID; VITAMIN K GROUP; CHOLAGOGUE; GLUCOCORTICOID;

ADULT; ARTICLE; ASCITES; AUTOIMMUNE HEPATITIS; CASE REPORT; CLINICAL FEATURE; COOMBS TEST; DRUG RESPONSE; ECHOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MENTAL DETERIORATION; MORTALITY; PRIMARY BILIARY CIRRHOSIS; RETICULOCYTOSIS; BILIARY CIRRHOSIS; MIDDLE AGED;

CHOLAGOGUES AND CHOLERETICS; FEMALE; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FAILURE; MIDDLE AGED; PREDNISOLONE; URSODEOXYCHOLIC ACID;

EID: 85047694149     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(04)00087-8     Document Type: Article

References (20)

1. Herzog D, Rasquin-Weber AM, Debray D, Alvarez F. Subfulminant hepatic failure in autoimmune hepatitis type 1: An unusual form of presentation. J Hepatol 1997;27:578-82.
2. Van Leeuwen DJ, Sood G, Ferrante D, Lazenby AJ, Sellers MJ. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": A missed opportunity! Semin Liver Dis 2002;22:395-406.
3. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancada EL, et al. International Autoimmune Hepatitis Study Group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;3:929-38.
4. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996;125:588-98.
5. Woodward J, Neberger J. Autoimmune overlap syndromes. Hepatology 2001;33:994-1002.
6. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998;28:360-5.
7. Lohse AW, Gerken G, Mohr H, Lohr HF, Treichel U, Dienes HP, et al. Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients. Z Gastroenterol 1995;33:527-33.
8. Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: An evaluation of a modified scoring system. Am J Gastroenterol 2002;97:1191-7.
9. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986;31:705-11.
10. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998;28:296-301.
11. Lohse AW, Meyer zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29:1078-84.
12. Dienes HP, Erberich H, Dries V, Schirmacher P, Lohse A. Autoimmune hepatitis and overlap syndromes. Clin Liver Dis 2002;6:349-62.
13. Gunsar F, Akarca U, Ersoz G, Karasu Z, Yuce G, Batur Y. Biochemical, histological parameters and response to UDCA treatment in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 2001;34:216.
14. Trey C, Davidson LS. The management of fulminant hepatic failure. In: Popper H, Shaffner F, editors. Progress in liver disease. New York: Grune and Stratton; 1970. p. 282.
15. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: Definitions and causes. Semin Liver Dis 1986;6:97-106.
16. Sasaki H, Inoue K, Higuchi K, Yasuyama T, Koyata H, Kuroki T, et al. Primary biliary cirrhosis in Japan: National survey by the Subcommittee on Autoimmune hepatitis. Gastroenterol Jpn 1985;20:476-85.
17. Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodes J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980;78:236-46.
18. Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of primary biliary cirrhosis. J Hepatol 1996;25:49-57.
19. Muratori L, Cassani F, Pappas G, Guidi M, Mele L, Lorenza V, et al. The hepatic/cholestatic overlap syndrome: An Italian experience. Autoimmunity 2002;35:565-8.
20. Floreani A, Baragiotta A, Guido M. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: A cause of resistance to ursodeoxycholic treatment. Dig Liver Dis 2003;35:128-9.